Reading File
Finding Sources
Finding Sources
Searching PubMed

congenital diaphragmatic hernia prenatal diagnosis management

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Here is a thorough explanation of this ultrasound report for Mrs. Priyanka Ninama.

Ultrasound Report Explained - Mrs. Priyanka Ninama (33 Weeks 1 Day)

Basic Details

ParameterFinding
PatientPriyanka Ninama, 20 years, Female
Scan typeOB 2/3 Trimester Growth Scan
Visit Date20 July 2026
Gestational Age33 Weeks 1 Day (by biometry: BPD, HC, AC, FL)
Corrected EDD06 September 2026

Fetal Measurements (Biometry)

These measurements tell us how big the baby's body parts are compared to expected values for gestational age:
MeasurementValueWhat It Means
BPD (Biparietal Diameter - head width)8.25 cmCorresponds to 33W 2D - normal
HC (Head Circumference)30.34 cmCorresponds to 33W 5D - normal
AC (Abdominal Circumference)29.01 cmCorresponds to 33W 0D - normal
FL (Femur Length)6.34 cmCorresponds to 32W 5D - slightly less but within range
Estimated Fetal Weight2104 gm ± 307 gmNormal for 33 weeks (expected ~1800-2200 gm)
All measurements are consistent with 33 weeks - baby's growth is appropriate.

Other Findings

1. Presentation - Breech The baby is currently positioned feet/bottom-first rather than head-down. At 33 weeks this is not unusual - most babies turn to head-down (cephalic) position by 36 weeks, so there is still time. The obstetric team will monitor this and discuss options if the baby remains breech closer to delivery.
2. Placenta - Posterior Grade III
  • Posterior: the placenta is on the back wall of the uterus - a normal location.
  • Grade III: indicates a mature placenta. Grade III at 33 weeks is slightly early (usually expected at 36+ weeks), but in combination with the other findings (especially polyhydramnios), the obstetrician needs to be informed.
3. Liquor Increased - Polyhydramnios (AFI 22.11 cm)
  • AFI (Amniotic Fluid Index) of 22.11 cm is elevated (normal range: 8-18 cm; above 20-25 cm is considered polyhydramnios).
  • Polyhydramnios can occur when the fetus is not swallowing amniotic fluid normally - which is strongly linked to the next finding (CDH), as a baby whose stomach/bowel is displaced into the chest may have difficulty swallowing.
4. Cardiac Activity: 149 bpm - Normal (normal fetal heart rate: 110-160 bpm).
5. Umbilical Cord: 2 arteries and 1 vein - This is completely normal.
6. Cervix: 4.1 cm, internal os closed - Good cervical length, no signs of preterm labor.

The Most Important Finding: Suspected Congenital Diaphragmatic Hernia (CDH)

"Fetus stomach, bowel loops or herniated content seen in thoracic region - Diaphragmatic hernia"
This is the critical finding in this report.
What is CDH? The diaphragm is the muscle sheet that separates the chest (thorax) from the abdomen. In Congenital Diaphragmatic Hernia, there is a defect (hole) in the diaphragm through which abdominal organs - usually the stomach, bowel, and sometimes liver - herniate (push up) into the chest cavity.
  • Incidence: approximately 1 in 3,000 to 5,000 live births
  • Left-sided herniation is most common (about 90% of cases)
  • It is frequently first detected on a routine obstetric ultrasound, exactly as in this case
Why is it serious? As explained in Morgan & Mikhail's Clinical Anesthesiology: when the gut herniates into the chest, it compresses the developing lungs. This leads to:
  1. Pulmonary hypoplasia (underdeveloped lungs) - the herniated gut compresses and retards maturation of both lungs, especially the same-side lung
  2. Pulmonary hypertension (high blood pressure in the lungs) after birth
  3. Ventricular dysfunction - stress on the heart
According to Creasy & Resnik's Maternal-Fetal Medicine: "The degree of pulmonary hypoplasia in CDH is directly related to the extent of herniation. Large hernias occur earlier in gestation. In most cases, the contralateral lung is also hypoplastic." The interplay of pulmonary hypoplasia, pulmonary hypertension, and ventricular dysfunction determines the baby's survival.
CDH carries a reported 40-50% mortality rate, though outcomes vary significantly based on the size of the defect, which organs have herniated, and whether the liver has entered the chest.
The connection to polyhydramnios: The baby with CDH has stomach/bowel displaced into the chest. This disrupts normal fetal swallowing of amniotic fluid, which is why the amniotic fluid has accumulated (polyhydramnios, AFI 22.11 cm).

What Happens Next - Immediate Steps Required

This is a finding that requires urgent referral to a specialist centre. Here is what the medical team will typically do:
  1. Referral to a Fetal Medicine Unit / Tertiary Centre - This is the most important step. CDH requires management by a multidisciplinary team including maternal-fetal medicine specialists, neonatologists, and pediatric surgeons.
  2. Detailed Anomaly Scan - A targeted scan by a fetal medicine specialist to confirm the diagnosis, assess which organs are herniated (stomach, bowel, liver), and measure the lung-to-head ratio (LHR) or observed/expected LHR - this predicts lung development and prognosis.
  3. Fetal MRI - May be recommended to better assess the extent of herniation and estimate fetal lung volumes. A 2026 systematic review (PMID: 41319474) confirms prenatal ultrasound and MRI are the key tools for predicting survival in severe CDH.
  4. Chromosomal/Genetic Testing - CDH can be associated with chromosomal abnormalities (e.g., Trisomy 18, 21); genetic counselling may be advised.
  5. Echocardiography (fetal echo) - To assess cardiac anatomy (CDH is associated with congenital heart defects) and early signs of pulmonary hypertension.
  6. Delivery Planning - Delivery should be planned at a tertiary centre with a Level III NICU and pediatric surgical capability. The baby will likely need immediate intubation and respiratory support at birth.
  7. Postnatal surgical repair - The defect is repaired surgically, but not immediately at birth. The current approach is to stabilize the newborn first (sometimes using ECMO if needed), and only perform surgery once the baby is hemodynamically stable. As noted in Mulholland & Greenfield's Surgery: "CDH is a physiologic emergency and not a surgical emergency."

Summary for the Family

  • Baby's growth is normal for 33 weeks.
  • The scan has found a serious condition where the baby's stomach and bowel appear to be inside the chest cavity instead of the abdomen. This is called Congenital Diaphragmatic Hernia.
  • This is not something that can be fixed before birth in most settings.
  • The baby will need specialized care immediately after delivery, including a breathing tube, possible surgery, and intensive care.
  • The family should be referred urgently to a tertiary hospital with a Neonatal Intensive Care Unit (NICU) and pediatric surgical team so that delivery can be planned and the baby receives the best possible care from the moment of birth.
  • The other aspects of the scan (growth, heartbeat, cervix) are reassuring, but this finding needs prompt specialist attention.

Important: This explanation is for informational purposes. The family should consult their obstetrician immediately and follow their advice for urgent referral to a specialist centre.

Management

Finding Sources
Finding Sources
Finding Sources
Searching PubMed

congenital diaphragmatic hernia management neonatal outcomes

Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Here is a complete, structured management guide for CDH, tailored to this case.

Management of Congenital Diaphragmatic Hernia (CDH)

Based on this ultrasound finding at 33 weeks, management is divided into three phases: Antenatal (remaining pregnancy), Neonatal Stabilization, and Surgical Repair, followed by long-term follow-up.

PHASE 1 - Antenatal Management (Now, at 33 Weeks)

1. Urgent Referral to a Tertiary/Fetal Medicine Centre

The single most important step right now. As stated in Creasy & Resnik's Maternal-Fetal Medicine: "Diagnosis of CDH should prompt referral to a tertiary center that is experienced in assessing this anomaly and managing CDH in the perinatal period." A centre with a Level III NICU and pediatric surgical team is mandatory.

2. Confirm and Characterize the Diagnosis

A detailed workup at the tertiary centre includes:
InvestigationPurpose
Detailed anomaly ultrasoundConfirm CDH; identify which organs are herniated (stomach, bowel, liver); assess liver position (liver-up vs liver-down - prognostic)
Lung-to-Head Ratio (LHR) / O/E LHRKey prognostic tool - measures contralateral lung area divided by head circumference; expressed as observed/expected (O/E LHR) for gestational age
Fetal MRIBetter visualization of lung volumes, liver position, and extent of herniation than ultrasound alone
Fetal echocardiographyRule out congenital heart defects (associated in ~30% of CDH cases); detect early pulmonary hypertension signs
Chromosomal/Genetic testingArray CGH or karyotype - CDH is associated with trisomies and microdeletions; associated anomalies raise mortality to >85%
Prognostic interpretation of O/E LHR (Sabiston Textbook of Surgery):
  • O/E LHR < 25% = severe CDH, ~15% survival without intervention
  • O/E LHR 25-35% = moderate CDH
  • O/E LHR > 45% = mild CDH, survival approaches 80-90%

3. Prenatal Intervention - FETO (Fetoscopic Endoluminal Tracheal Occlusion)

This is the only available fetal therapy for severe CDH. A small balloon is placed endoscopically to block the fetal trachea (usually at 27-29 weeks gestation), which causes lung fluid accumulation and stimulates lung growth. The balloon is removed several weeks later.
Evidence: The landmark TOTAL (Tracheal Occlusion to Accelerate Lung Growth) randomized controlled trial showed that in severe CDH (O/E LHR < 25%), FETO improved survival to discharge from 15% to 40%. The moderate CDH trial (O/E LHR 25-35%) did not show benefit. A 2026 systematic review (PMID: 41319474) confirms prenatal imaging and this prognostic stratification remain central to management.
Important for this case: At 33 weeks, the window for FETO (ideally 27-29 weeks) has already passed. Therefore, antenatal management will focus on delivery planning rather than fetal intervention.
Complications of FETO: Preterm labor, PPROM, premature birth, fetal demise - which is why timing matters.

4. Multidisciplinary Counselling

Parents must be counselled by maternal-fetal medicine, neonatology, pediatric surgery, and genetics. Informed decision-making about resuscitation options should be discussed given the prognosis, especially if additional anomalies are identified.

5. Delivery Planning

  • Delivery should occur at the tertiary centre (do NOT deliver at a peripheral hospital)
  • Timing: CDH itself is not an indication for preterm delivery; aim for term unless obstetric indications arise
  • Mode: Vaginal delivery is generally acceptable; caesarean section only for obstetric indications
  • A neonatal resuscitation team (neonatologist, pediatric surgeon, NICU) must be present at delivery

PHASE 2 - Neonatal Stabilization (Immediately After Birth)

Key principle: CDH is a PHYSIOLOGIC emergency, not a surgical emergency. Stabilize first, operate later.

Immediate Resuscitation

  • Immediate intubation at delivery - do NOT attempt bag-mask ventilation (risks gastric distension and further lung compression)
  • Insert a nasogastric tube for gastric decompression
  • Avoid nitrous oxide (causes bowel gas expansion)
  • Limit peak inspiratory pressure < 25 cmH₂O to prevent barotrauma
  • Target preductal SpO₂ 85-95%; accept mild hypoxemia rather than over-ventilate

Ventilatory Strategy - "Gentle Ventilation" (Gentilation)

The mainstay of CDH management per Sabiston Textbook of Surgery:
  • Permissive hypercapnia: allow PaCO₂ up to 60-65 mmHg (post-ductal)
  • Pressure-limited ventilation with low tidal volumes
  • High-Frequency Oscillatory Ventilation (HFOV) if conventional ventilation fails - provides better gas exchange with less barotrauma
  • Avoid aggressive ventilation that worsens pulmonary hypertension

Treatment of Pulmonary Hypertension

This is the key driver of mortality:
TreatmentMechanism
Inhaled Nitric Oxide (iNO)Selectively dilates pulmonary vasculature, reduces right-to-left shunting
Sildenafil (PDE-5 inhibitor)Pulmonary vasodilation (oral/IV)
Prostacyclin (PGI₂) / TreprostinilPulmonary vasodilators for refractory PH
MilrinoneInodilator - reduces pulmonary hypertension and supports cardiac function
PGE₁Maintains ductal patency in refractory cases

ECMO (Extracorporeal Membrane Oxygenation)

Used when the baby fails to stabilize despite maximal medical therapy:
  • Venoarterial (VA) ECMO preferred for combined cardiac and respiratory failure
  • Allows the lungs to "rest" while maintaining systemic perfusion
  • Bridging therapy until the baby is stable enough for surgery
  • As noted in Miller's Anesthesia: "Unstable neonates with CDH may require ECMO and inhaled nitric oxide" before surgery can be planned

PHASE 3 - Surgical Repair

Timing

  • Not an emergency - delay surgery until hemodynamic stability is achieved
  • In stable infants: defer repair 48-72 hours after birth to allow pulmonary vascular lability to settle (Sabiston)
  • In ECMO-dependent infants: timing is debated; some favour repair during ECMO, others after decannulation (bleeding risk is higher on ECMO)

Surgical Approach

Open repair (most common) via ipsilateral subcostal incision:
  1. Reduce herniated viscera back into the abdomen
  2. Excise hernia sac (if present)
  3. Identify and mobilize diaphragm leaflets
  4. Close the diaphragmatic defect
Closure technique:
  • Primary repair with interrupted non-absorbable sutures - preferred when possible
  • Patch repair (Gore-Tex / Surgisis) for large defects where primary closure would be under tension - patch repairs have higher recurrence rates but are necessary for large defects
Laparoscopic repair: feasible in stable infants with smaller defects; associated with higher recurrence rates than open repair; not suitable in hemodynamically unstable infants.
Thoracotomy approach: occasionally used for right-sided CDH.
If abdominal domain is lost after reduction: temporary abdominal silo or skin-only closure with delayed fascial repair.

PHASE 4 - Long-Term Follow-Up

Survivors of CDH require lifelong monitoring due to significant chronic morbidities (Sabiston):
SystemComplication
RespiratoryBronchopulmonary dysplasia, chronic lung disease, recurrent respiratory infections
CardiovascularPersistent pulmonary hypertension (PPHN), right ventricular dysfunction
GIGastroesophageal reflux disease (GERD), foregut dysmotility, feeding difficulties
MusculoskeletalScoliosis, pectus excavatum, chest wall deformity
NeurodevelopmentalDevelopmental delay, hearing loss, seizures (especially after prolonged NICU care/ECMO)
RecurrenceHernia recurrence - higher with patch repairs, requires surveillance
GrowthGrowth retardation
A 2025 systematic review (PMID: 40100453) confirms that CDH survivors have significant long-term morbidities beyond childhood, reinforcing the need for structured multi-specialty follow-up.

Summary Flowchart for This Case

33-week scan → CDH suspected
        ↓
URGENT referral to tertiary centre
        ↓
Detailed US + MRI + Fetal echo + Genetics
        ↓
FETO: NOT possible at 33 wks (window 27-29 wks)
        ↓
Plan delivery at tertiary centre (with NICU + peds surgery)
        ↓
At birth: Immediate intubation + NG tube
        ↓
Gentle ventilation + treat pulmonary hypertension
        ↓
If fails → ECMO
        ↓
Stabilise 48-72 hrs → Surgical repair
        ↓
Long-term NICU + multidisciplinary follow-up
Overall survival with modern neonatal care at high-volume centres: 65-90% for isolated CDH (Sabiston Textbook of Surgery). If associated with chromosomal anomalies or other structural defects, mortality exceeds 85%.
This is a shared conversation. Sign in to Orris to start your own chat.